# RejuvenAir™ System Lobectomy Safety and Histology Study

> **NCT02106143** · NA · COMPLETED · sponsor: **CSA Medical, Inc.** · enrollment: 11 (actual)

## Conditions studied

- Lung Neoplasms
- Airway Obstruction
- Lung Cancer

## Interventions

- **DEVICE:** RejuvenAir™ Radial Spray Cryotherapy

## Key facts

- **NCT ID:** NCT02106143
- **Lead sponsor:** CSA Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02106143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02106143, "RejuvenAir™ System Lobectomy Safety and Histology Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02106143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*